L2 Asset Management, LLC United Therapeutics Corp Transaction History
L2 Asset Management, LLC
- $326 Million
- Q2 2024
A detailed history of L2 Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, L2 Asset Management, LLC holds 2,364 shares of UTHR stock, worth $904,868. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,364
Previous 2,064
14.53%
Holding current value
$904,868
Previous $474,000
58.86%
% of portfolio
0.23%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding UTHR
# of Institutions
642Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$2.09 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.69 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.26 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.09 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$878 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...